Respiratory syncytial virus (RSV) causes infection of respiratory system (lungs and breathing passage). It may also affect heart and immune system resulting in more serious illnesses (e.g. tachypnea, cyanosis).
Premature infants (30-40 days) and children (less than 2 year of age) are at the highest risk of this infection. According to the U.S. Centre for Disease Control and Prevention (CDC), RSV is the common cause of bronchiolitis or pneumonia in the children under one year of age in the United States.
Obtain Report Details @ https://www.transparencymarketresearch.com/respiratory-syncytial-virus-diagnostic-testing.html
Each year 75,000 to 125,000 children are hospitalized due to RSV infections. This Infection can result from the direct (i.e. kiss, touch or shake hands with infected person) or indirect contact (i.e. contact with sneeze, cough or blows of infected person)with the infected person. Mild headache, runny nose, cough and sore throat are some of the common symptoms of RSV viral infections.
Diagnosis of these infections is facilitated by specific tests like polymerase chain reaction assay, molecular probes, chest radiography. Physicians also administer intubation (breathing tube), mechanical ventilation or some antibiotics (like palivizumab) in order to treat the patients with RSV infections.
Increasing incidences of childhood pneumonia, acts as one of the major factors to drive the growth of RSV diagnostic testing market. According to the data enumerated by World Health Organization (WHO), in 2010, approximately 1.1 million people in the United States were hospitalized with pneumonia and 50,000 people died from this disease.
Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2065
In addition, crowded population and unhygienic environment (dirty premises, unhygienic eating places) may increase the chances of RSV infection thereby resulting in increased need and demand for effective RSV diagnostic tests. However, high number of other pathogens that may cause similar symptoms of respiratory illness and lack of availability of specific treatment options to curb this infection may restrain the growth of this market.
The global Respiratory Syncytial Virus Diagnostic Testing Market can be segmented as follows:
By Diagnostic Technology
Molecular Diagnostics
Immunoassays
Monoclonal Antibodies
Flow Cytometry
Diagnostic Imaging
Chromatography
Gel Microdroplets
Others
By End Users
Physician offices or group practices
Hospitals
Commercial Laboratories
Nursing Homes
Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2065
Geographically, North America and Europe dominate the global RSV diagnostic testing market due to increasing patient population suffering from respiratory syncytial virus. According to the U.S. CDC, approximately 50,000 deaths are noted due to pneumonia in the United States in year of 2012.In addition, Asia-Pacific countries such as India and China, South East Asian countries are the emerging regions for global RSV diagnostic testing market due to high prevalence of these diseases (i.e. pneumonia, bronchitis) in these regions and increasing healthcare awareness.